Foresee Pharmaceuticals Co., Ltd. (TPEX:6576)
Taiwan · Delayed Price · Currency is TWD 75.40
-1.60 (-2.08%)
Aug 12, 2025, 1:30 PM CST
Ligand Pharmaceuticals Market Cap
Foresee Pharmaceuticals has a market cap or net worth of 11.92 billion as of August 11, 2025. Its market cap has increased by 5.18% in one year.
Market Cap
11.92B
Enterprise Value
11.05B
Revenue
425.30M
Ranking
n/a
PE Ratio
n/a
Stock Price
$75.40
Market Cap Chart
Since April 12, 2016, Foresee Pharmaceuticals's market cap has increased from 7.35B to 11.92B, an increase of 62.20%. That is a compound annual growth rate of 5.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 11.92B | -0.60% |
| Dec 31, 2024 | 12.00B | -8.16% |
| Dec 29, 2023 | 13.06B | 20.98% |
| Dec 30, 2022 | 10.80B | -23.14% |
| Dec 30, 2021 | 14.05B | 34.12% |
| Dec 31, 2020 | 10.47B | 79.10% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Apr 12, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 207.84B |
| PharmaEssentia | 166.30B |
| Bora Pharmaceuticals Co., LTD. | 88.86B |
| Lotus Pharmaceutical | 56.28B |
| Oneness Biotech | 30.90B |
| Polaris Group | 27.31B |
| Center Laboratories | 26.39B |
| Pegavision | 24.38B |